|
CA3114592A1
|
|
Benzimidazole derivative for use in the treatment of inflammatory disorders
|
|
AR114886A1
|
|
PROCESS TO PREPARE 2 - [[5- (3-CHLOROPHENYL) -3-HYDROXYPYRIDIN-2-CARBONYL] AMINO] ACETIC ACID
|
|
WO2019028150A1
|
|
Compositions for use in methods of treatment of hemoglobin disorders
|
|
ZA201704677B
|
|
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid,compositions,and uses thereof
|
|
CN107645953A
|
|
For treating the composition and method of anaemia
|
|
AU2016235534A1
|
|
Deuterium-enriched hypoxia-inducible factor prolyl hydroxylase enzyme inhibitors
|
|
WO2016118858A1
|
|
Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
|
|
CN106132201A
|
|
For treating compositions and the method for ocular disease
|
|
WO2015073779A1
|
|
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
|
|
MX2015017229A
|
|
Compositions and methods for treating anemia.
|
|
MA38670A1
|
|
Compositions and methods of treatment of anemia
|
|
CA2838194A1
|
|
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
|
|
WO2012170442A1
|
|
Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
|
|
SG189177A1
|
|
Compositions and methods for treating ocular edema, neovascularization and related diseases
|
|
AU2007265460A1
|
|
Prolyl hydroxylase inhibitors and methods of use
|
